Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
bluebird bio, Inc. (BLUE) had Stock-Based Compensation of $13.74M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$38.52M |
|
$-28.71M |
|
$22.79M |
|
$15.73M |
|
$74.98M |
|
$-36.46M |
|
$7.86M |
|
$-28.60M |
|
$-28.60M |
|
$-28.71M |
|
$-28.71M |
|
$-28.71M |
|
$-28.71M |
|
$-36.46M |
|
$-22.55M |
|
9.69M |
|
9.69M |
|
$-3.04 |
|
$-3.04 |
|
| Balance Sheet Financials | |
$154.67M |
|
$60.85M |
|
$305.56M |
|
$460.23M |
|
$321.46M |
|
$7.80M |
|
$170.30M |
|
$491.77M |
|
$-31.53M |
|
$-46.73M |
|
$-31.53M |
|
9.73M |
|
| Cash Flow Statement Financials | |
$-260.02M |
|
$3.90M |
|
$87.47M |
|
$274.60M |
|
$105.94M |
|
$-168.65M |
|
|
Stock-Based Compensation |
$13.74M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.48 |
|
-- |
|
-- |
|
-0.33 |
|
-5.83 |
|
40.84% |
|
-94.64% |
|
-94.64% |
|
-- |
|
-74.25% |
|
-74.53% |
|
$-262.62M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.35 |
|
12.45 |
|
7.23 |
|
91.05% |
|
61.44% |
|
-6.24% |
|
120.95% |
|
$-3.24 |
|
$-27.10 |
|
$-26.84 |
|